Global Information
회사소개 | 문의

세계의 심장 페이스메이커 시장 : 의료기기 파이프라인 평가

Pacemakers - Medical Devices Pipeline Assessment, 2018

리서치사 GlobalData
발행일 2018년 06월 상품 코드 363397
페이지 정보 영문
가격
US $ 2,500 ₩ 2,822,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,644,000 PDF by E-mail (Site License) help
동일 사업장 내 모든 분들이 공유하여 사용할 수 있습니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 2부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 7,500 ₩ 8,466,000 PDF by E-mail (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없으며, 해외 사업장 및 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. PDF 내의 컨텐츠 인쇄는 제한이 없으나, 전체보고서에 대한 제본은 원칙적으로 10부까지만 허용되며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 심장 페이스메이커 시장 : 의료기기 파이프라인 평가 Pacemakers - Medical Devices Pipeline Assessment, 2018
발행일 : 2018년 06월 페이지 정보 : 영문

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

한글목차

세계 심장 페이스메이커(Cardiac Pacemakers) 시장의 주요 파이프라인 제품과 그 임상시험 진행 상황에 대해 조사했으며, 제품 기능과 특성 비교 분석(임상시험 진행 단계별), 주요 기업 개요 및 대표적 제품, 최근 시장 동향(실적 보고 및 자본 거래 동향 등) 등의 정보를 전해드립니다.

제1장 목차

제2장 서론

  • 심장 페이스메이커 개요

제3장 임상시험중인 제품

  • 파이프라인 제품 : 임상 단계별
  • 파이프라인 제품 : 분야별
  • 파이프라인 제품 : 지역별
  • 파이프라인 제품 : 규제 경로별
  • 파이프라인 제품 : 추정 인증 시기별
  • 파이프라인 제품 : 현재 진행중인 임상시험

제4장 임상시험중인 파이프라인 제품 : 기업별

  • 심장 페이스메이커 기업 : 임상 단계별 파이프라인 제품
  • 심장 페이스메이커 : 임상 단계별 파이프라인 제품

제5장 심장 페이스메이커 시장 : 기업 및 제품 개요

  • Boston Scientific Corporation
    • 파이프라인 제품 및 진행중인 임상시험 개요
  • Boston TransTec, LLC
  • Duke University
  • EBR Systems, Inc.
  • Hadasit Medical Research Services & Development Ltd
  • InnerPulse, Inc.
  • Kenergy Inc.
  • Krisara Engineering, LLC
  • LivaNova PLC
  • Mathematical Bio-Solutions Inc.
  • Mayo Clinic US
  • Medtronic plc
  • MicroPort Scientific Corporation
  • NDSU Research Foundation
  • NuVascular Technologies Inc
  • Perpetuum Ltd.
  • St. Jude Medical, Inc.
  • University of Bern
  • University of California, Los Angeles
  • University of Michigan

제6장 심장 페이스메이커 시장 : 최근의 동향(총 63건)

제7장 부록

도표

KSM 16.07.29

List of Tables

  • Table 1: Pacemakers - Pipeline Products by Stage of Development
  • Table 2: Pacemakers - Pipeline Products by Segment
  • Table 3: Pacemakers - Pipeline Products by Territory
  • Table 4: Pacemakers - Pipeline Products by Regulatory Path
  • Table 5: Pacemakers - Pipeline Products by Estimated Approval Date
  • Table 6: Pacemakers - Ongoing Clinical Trials
  • Table 7: Pacemakers Companies - Pipeline Products by Stage of Development
  • Table 8: Pacemakers - Pipeline Products by Stage of Development
  • Table 9: BackBeat Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 10: Moderato - Product Status
  • Table 11: Moderato - Product Description
  • Table 12: BackBeat Medical, Inc. - Ongoing Clinical Trials Overview
  • Table 13: Moderato - Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients with Hypertension - A Double-Blind Randomized Trial - PV Loops Sub Study
  • Table 14: Moderato - Clinical Evaluation of Safety and Effectiveness of the BackBeat Medical Moderato System in Patients with Hypertension: A Double-blind Randomized Trial
  • Table 15: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
  • Table 16: Heart Pacing System - Product Status
  • Table 17: Heart Pacing System - Product Description
  • Table 18: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 19: EMPOWER Leadless Pacer - Product Status
  • Table 20: EMPOWER Leadless Pacer - Product Description
  • Table 21: INGENIO 2 PG - MICS - Product Status
  • Table 22: INGENIO 2 PG - MICS - Product Description
  • Table 23: Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: Raul Pacemaker - Product Status
  • Table 25: Raul Pacemaker - Product Description
  • Table 26: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Biological Pacemaker - Product Status
  • Table 28: Biological Pacemaker - Product Description
  • Table 29: Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Tissue-Engineered Autonomous Pacemaker - Product Status
  • Table 31: Tissue-Engineered Autonomous Pacemaker - Product Description
  • Table 32: Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 33: Aortic Pacemaker - Product Status
  • Table 34: Aortic Pacemaker - Product Description
  • Table 35: InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 36: InnerPulse Pacemaker - Product Status
  • Table 37: InnerPulse Pacemaker - Product Description
  • Table 38: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: Unconditional MRI Compatible Implantable Pacemaker - Product Status
  • Table 40: Unconditional MRI Compatible Implantable Pacemaker - Product Description
  • Table 41: Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 42: Wireless Pacemaker - Product Status
  • Table 43: Wireless Pacemaker - Product Description
  • Table 44: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Reply MRI Pacemaker - Product Status
  • Table 46: Reply MRI Pacemaker - Product Description
  • Table 47: Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: ECN Pacemaker - Product Status
  • Table 49: ECN Pacemaker - Product Description
  • Table 50: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Brady Wireless - Product Status
  • Table 52: Brady Wireless - Product Description
  • Table 53: Heart Pacemaker - Product Status
  • Table 54: Heart Pacemaker - Product Description
  • Table 55: Micra AAIR Pacemaker - Product Status
  • Table 56: Micra AAIR Pacemaker - Product Description
  • Table 57: Micra DDDR Pacemaker - Product Status
  • Table 58: Micra DDDR Pacemaker - Product Description
  • Table 59: Micra VDDR Pacemaker - Product Status
  • Table 60: Micra VDDR Pacemaker - Product Description
  • Table 61: NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: Multi-Electrode Cardiac Pacing System - Product Status
  • Table 63: Multi-Electrode Cardiac Pacing System - Product Description
  • Table 64: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Biological Pacemaker - Product Status
  • Table 66: Biological Pacemaker - Product Description
  • Table 67: Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: PACE 300 - Product Status
  • Table 69: PACE 300 - Product Description
  • Table 70: Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Implantable Self-Energising Pacemaker - Product Status
  • Table 72: Implantable Self-Energising Pacemaker - Product Description
  • Table 73: Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Battery-Less Pacemaker - Product Status
  • Table 75: Battery-Less Pacemaker - Product Description
  • Table 76: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Nanostim Leadless Pacemaker - Product Status
  • Table 78: Nanostim Leadless Pacemaker - Product Description
  • Table 79: St. Jude Medical LLC - Ongoing Clinical Trials Overview
  • Table 80: Nanostim Leadless Pacemaker - Nanostim Study for a Leadless Cardiac Pacemaker System
  • Table 81: Nanostim Leadless Pacemaker - Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker
  • Table 82: U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: BioPace - Product Status
  • Table 84: BioPace - Product Description
  • Table 85: University of Bern Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: Batteryless Cardiac Pacemaker - Product Status
  • Table 87: Batteryless Cardiac Pacemaker - Product Description
  • Table 88: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • Table 89: MR3 Next-Generation Pacemaker - Product Status
  • Table 90: MR3 Next-Generation Pacemaker - Product Description
  • Table 91: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • Table 92: Cardiac Energy Harvesting Pacemaker - Product Status
  • Table 93: Cardiac Energy Harvesting Pacemaker - Product Description
  • Table 94: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview
  • Table 95: Fetal Micro-Pacemaker - Product Status
  • Table 96: Fetal Micro-Pacemaker - Product Description
  • Table 97: Glossary

List of Figures

  • Figure 1: Pacemakers - Pipeline Products by Stage of Development
  • Figure 2: Pacemakers - Pipeline Products by Segment
  • Figure 3: Pacemakers - Pipeline Products by Territory
  • Figure 4: Pacemakers - Pipeline Products by Regulatory Path
  • Figure 5: Pacemakers - Pipeline Products by Estimated Approval Date
  • Figure 6: Pacemakers - Ongoing Clinical Trials

영문목차

GlobalData's Medical Devices sector report, "Pacemakers - Medical Devices Pipeline Assessment, 2018" provides an overview of Pacemakers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pacemakers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope:

  • Extensive coverage of the Pacemakers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Pacemakers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy:

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Pacemakers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Pacemakers Overview

3. Products under Development

  • 3.1. Pacemakers - Pipeline Products by Stage of Development
  • 3.2. Pacemakers - Pipeline Products by Segment
  • 3.3. Pacemakers - Pipeline Products by Territory
  • 3.4. Pacemakers - Pipeline Products by Regulatory Path
  • 3.5. Pacemakers - Pipeline Products by Estimated Approval Date
  • 3.6. Pacemakers - Ongoing Clinical Trials

4. Pacemakers - Pipeline Products under Development by Companies

  • 4.1. Pacemakers Companies - Pipeline Products by Stage of Development
  • 4.2. Pacemakers - Pipeline Products by Stage of Development

5. Pacemakers Companies and Product Overview

  • 5.1. BackBeat Medical, Inc. Company Overview
    • 5.1.1. BackBeat Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Ben-Gurion University of the Negev Company Overview
    • 5.2.1. Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Boston Scientific Corp Company Overview
    • 5.3.1. Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Boston TransTec LLC Company Overview
    • 5.4.1. Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Columbia University Company Overview
    • 5.5.1. Columbia University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Duke University Company Overview
    • 5.6.1. Duke University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Hadasit Medical Research Services and Development Ltd Company Overview
    • 5.7.1. Hadasit Medical Research Services and Development Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. InnerPulse Inc (Inactive) Company Overview
    • 5.8.1. InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Kenergy Inc. Company Overview
    • 5.9.1. Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Krisara Engineering, LLC Company Overview
    • 5.10.1. Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. LivaNova PLC Company Overview
    • 5.11.1. LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Mathematical Bio-Solutions Inc. Company Overview
    • 5.12.1. Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Medtronic plc Company Overview
    • 5.13.1. Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. NDSU Research Foundation Company Overview
    • 5.14.1. NDSU Research Foundation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. NuVascular Technologies Inc Company Overview
    • 5.15.1. NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. Osypka Medical GmbH Company Overview
    • 5.16.1. Osypka Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. Perpetuum Ltd. Company Overview
    • 5.17.1. Perpetuum Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Rice University Company Overview
    • 5.18.1. Rice University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. St. Jude Medical LLC Company Overview
    • 5.19.1. St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. U.S. Stem Cell Inc Company Overview
    • 5.20.1. U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. University of Bern Company Overview
    • 5.21.1. University of Bern Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. University of California Los Angeles Company Overview
    • 5.22.1. University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. University of Michigan Company Overview
    • 5.23.1. University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Southern California Company Overview
    • 5.24.1. University of Southern California Pipeline Products & Ongoing Clinical Trials Overview

6. Pacemakers- Recent Developments

  • 6.1. May 11, 2018: New Study Demonstrates Feasibility of Novel Mechanical Sensor in Medtronic Micra Transcatheter Pacing System to Detect Atrial Contractions and Restore AV Synchrony
  • 6.2. May 09, 2018: Data Reinforce Reduced Complications with Medtronic Micra Transcatheter Pacing System Over Traditional Pacemakers in Real-World Use
  • 6.3. May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
  • 6.4. May 03, 2018: Integer Holdings Reports First Quarter 2018 Results
  • 6.5. Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
  • 6.6. Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
  • 6.7. Apr 03, 2018: Nihon Kohden Announces Change in Representative Director and Director
  • 6.8. Mar 26, 2018: Solid ion conductors could improve pacemaker safety and reliability
  • 6.9. Mar 06, 2018: Presbyterian Heart and Vascular Care First Team in Albuquerque to Offer the World's Smallest Pacemaker
  • 6.10. Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
  • 6.11. Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017
  • 6.12. Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives
  • 6.13. Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors
  • 6.14. Feb 08, 2018: MemorialCare Saddleback Medical Center Offers World's Smallest Pacemaker the Size of a Vitamin Weighing Less Than a Penny
  • 6.15. Feb 07, 2018: TMC: Small Device Promises Big Fix
  • 6.16. Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
  • 6.17. Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
  • 6.18. Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
  • 6.19. Jan 25, 2018: MSC Hosts Product Launch of Rega Family Implantable Pacemakers
  • 6.20. Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
  • 6.21. Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
  • 6.22. Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer
  • 6.23. Dec 22, 2017: Boston Scientific pacemakers and defibrillators
  • 6.24. Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
  • 6.25. Dec 18, 2017: Lifetech HeartTone Implantable Cardiac Pacemaker Receives Approval in China
  • 6.26. Dec 18, 2017: The CFDA Approves Impulse Dynamics' Optimizer System for Treatment of Chronic Heart Failure in China
  • 6.27. Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
  • 6.28. Nov 20, 2017: Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers
  • 6.29. Nov 09, 2017: JMS: Financial Results for the Second Quarter of Fiscal Year Ending March 31, 2018
  • 6.30. Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
  • 6.31. Nov 02, 2017: Salem Health offers world's smallest pacemaker
  • 6.32. Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
  • 6.33. Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results
  • 6.34. Nov 02, 2017: Nihon Kohden opens a sales branch in Kenya
  • 6.35. Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017
  • 6.36. Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results
  • 6.37. Oct 25, 2017: New device based treatment for patients with Chronic Heart Failure now available in the Nordic region
  • 6.38. Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
  • 6.39. Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
  • 6.40. Sep 27, 2017: LivaNova and MicroPort Announce the Approval of Rega Pacemakers by the China Food and Drug Administration
  • 6.41. Sep 12, 2017: MicroPort Sorin CRM: First Domestically Made World-Class Pacemaker Device Gains CFDA Approval
  • 6.42. Aug 22, 2017: Medtronic Reports First Quarter Financial Results
  • 6.43. Aug 17, 2017: First Leadless Pacemaker has been inserted at Peninsula Private Hospital
  • 6.44. Aug 17, 2017: First Leadless Pacemaker has been inserted at Peninsula Private Hospital
  • 6.45. Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
  • 6.46. Aug 09, 2017: JMS: Financial Results for the First Quarter of Fiscal Year Ending March 31, 2018
  • 6.47. Aug 02, 2017: SAMHSA announces $6 million in grants to support the International President's Emergency Plan for AIDS Relief Addiction Technology Transfer Centers
  • 6.48. Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017
  • 6.49. Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results
  • 6.50. Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer
  • 6.51. Jul 13, 2017: Nihon Kohden Selected for FTSE4Good Index Series and FTSE Blossom Japan Index
  • 6.52. Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
  • 6.53. Jun 19, 2017: Europace-Cardiostim 2017: Challenges and New Opportunities in Heart Failure Management
  • 6.54. Jun 13, 2017: Nihon Kohden to reorganize its group companies in India
  • 6.55. Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel
  • 6.56. Jun 05, 2017: Rice University: Texas team debuts battery-less pacemaker

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer
Back to Top
아시아 최대 시장정보 제공
전세계에서 발행되고 있는 모든 시장조사보고서를
다루고 있습니다.
사이트에서 검색되지 않는 보고서도 문의 바랍니다.
 
BCC Research